Skip to main content
. 2017 May 31;12(5):e0178515. doi: 10.1371/journal.pone.0178515

Fig 2. Immunohistochemical staining for MAL2 and TPD52 in human CRC tissues.

Fig 2

(A,B) Expression levels of MAL2 and TPD52 in primary carcinoma tissuesand liver metastasis tissues from patients with CRC were detected by immunohistochemical staining (×100, 100 μm; ×400, 20 μm). MAL2 and TPD52 expression levels were quantified as shown as the right bar charts. *P<0.05 compared with primary carcinoma; N.S., no significance.